Abstract:Background: The development of drug resistance and the persistence of leukemia stem cells are major obstacles for the use of tyrosine kinase inhibitors (TKIs) in the treatment of chronic myeloid leukemia (CML). The induction of autophagic death in tumor cells represents a new route for leukemia treatment. Our previous study showed that infection of CML cells with oncolytic viruses carrying the autophagy gene Beclin1 downregulated BCR/ABL protein expression and significantly increased the killing effect of the oncolytic viruses on CML cells via autophagy activation. However, the specific molecular mechanisms underlying the regulation of BCR/ABL and Beclin1-dependent CML cell killing remain unclear. Methods: A physical interaction between BCR/ABL and Beclin1 was characterized via GST-pulldown, co-IP and dual-luciferase reporter assays. Cell proliferation was examined via CCK-8 and clone formation assays. The expression levels of the related proteins were measured via Western blotting. Autophagosomes were observed under transmission electron microscopy. Lentiviral vectors carrying Atg7/UVRAG shRNA or the Beclin1 gene were used to modulate the expression levels of the indicated genes. Immunofluorescence were performed to examine colocalization of BCR/ABL and p62/SQSTM1. CD34(+)CD38(-) cells were isolated from bone marrow samples from CML patients via fluorescence-activated cell sorting. Results: In this study, we observed that Beclin1 directly interacts with BCR/ABL. Beclin1 inhibited the activity of the BCR/ABL promoter to downregulate the level of BCR/ABL protein and to promote the downstream colocalization of p62/SQSTM1 and BCR/ABL to autolysosomes for degradation via activation of the autophagy signaling pathway. In CML cell lines, primary cells and CD34(+)CD38(-) leukemia stem cells, Beclin1 overexpression significantly inhibited cell growth and proliferation and induced autophagy. Conclusion: Taken together, our results suggest that autophagy induction via Beclin1 overexpression might offer new approaches for treating TKI-resistant CML and for promoting the clearance of leukemia stem cells, both of which have important clinical implications.

B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells

Knockdown of Eukaryotic Translation Initiation Factor 5A2 Enhances the Therapeutic Efficiency of Doxorubicin in Hepatocellular Carcinoma Cells by Triggering Lethal Autophagy

Blocking Bcl-2 leads to autophagy activation and cell death of the HEPG2 liver cancer cell line.

Apatinib Enhances Chemosensitivity of ABT-199 in Diffuse Large B-cell Lymphoma

Synergistic Lethality Effects of ABT-199 and Apatinib on DLBCL: Antitumor Efficacy and Underlying Mechanisms

Mechanism underlying drug resistance of HepG2/ADM cells silently reversed by lentivirus-mediated BC047440 gene during chemotherapy

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy.

The inhibition of Beclin1-dependent autophagy sensitizes PTC cells to ABT737-induced death

ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL

Resveratrol Induces Autophagic Apoptosis Via the Lysosomal Cathepsin D Pathway in Human Drug-Resistant K562/ADM Leukemia Cells.

The Novel Bh-3 Mimetic Apogossypolone Induces Beclin-1-And Ros-Mediated Autophagy in Human Hepatocellular Cells

Autophagy Inhibits Chemotherapy-Induced Apoptosis Through Downregulating Bad and Bim in Hepatocellular Carcinoma Cells.

A Study on the Mechanism of Adriamycin-Induced Apoptosis of Human Hepatic Carcinoma Cells

Influence of autophagy on radiosensitivity of lung adenocarcinoma cells

Overexpression of Bax Induces Apoptosis and Enhances Drug Sensitivity of Hepatocellular Cancer-9204 Cells.

Albendazole-induced Autophagy Blockade Contributes to Elevated Apoptosis in Cholangiocarcinoma Cells Through AMPK/mTOR Activation.

Abstract 4280: the Cycloartane Triterpenoid ADCX Impairs Autophagic Degradation Through Akt Overactivation and Promotes Apoptotic Cell Death in Multidrug-Resistant HepG2/ADM Cells

Dual PI3K/mTOR Inhibitor NVP-BEZ235-induced Apoptosis of Hepatocellular Carcinoma Cell Lines is Enhanced by Inhibitors of Autophagy

The BH3 mimetic ABT-737 induces cancer cell senescence

Autophagy Facilitates The Development Of Resistance To The Tumor Necrosis Factor Superfamily Member Trail In Breast Cancer

Interferon-alpha-2b Induces Autophagy in Hepatocellular Carcinoma Cells Through Beclinl Pathway